RVNC trade ideas

lord_catnip

Revance Therapeutics, Inc.( NASDAQ:RVNC ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $2.124B Current Price: $29.17 Breakout price: $30.00 Buy Zone (Top/Bottom Range): $27.45-$24.15 Price Target: $41.10-$42.00 Estimated Duration to Target: 132-142d Contract of Interest: $RVNC 1/20/23 30c Trade price as of publish date: $3.70/contract

fade_the_vol Updated 

Bought RVNC Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

ChartProphet

Here we have a clear gap to fill with momentum having shifted to the upside and of course insider buying as titled. Watch for continuation and set a short stop. NFA, DYOR

rok_trader

rvnc - long consolidation and accumulation. Break of ascending triangle probably to happen.

Igaln9

NASDAQ:RVNC RVNC trades on a ascending channel stoped exactly at the bottom of the support channel Entry : 25.3 SL: 23.95 TP1:28 TP2:3

GolfPapa79 Updated 

A weekly RSI divergence and a Wolfe wave at the same time on NASDAQ:RVNC biotech, good opportunity I think, with a good RR ratio. Divergence also visible on Monthly timeframe. I personnaly entered at $13.8, on the breakout of the double bottom. It's currently testing its MM50 3 TP for this trade : - TP1 : breakeven at $19.9 - TP2 : $29.9 - TP3 : wolfe wave...

Master_of_Fine_Charts

Forming a Cup & Handle on the daily after double bottom. 1st target 14.03 Very low float could make this a runner with a catalyst.

Jasky

break of market structure and making higher highs and lows. Gotta wait for the break of the blue zone to the upside which is a all time low key level. strong bias towards a buy.

dobisa Updated 

We are IMHO. Will this area hold? Who knows. But the RR looks pretty good to me.

RobertoJavierC

The graphic show a down trendline between 02/20/2019 and 05/24/2019, with the MACD we can see a down trend and a small volume, this can show that the graphic will still go down but we have to wait in till the market open on monday 05/27/2019

Kareim

Downward push signaled since 12-month resistance; early dip by oscillators.

Pinokio

RVNC jumped on a successful phase 3 clinical trials. It held its ground however there was a blow of top and retracement. (for education purposes)

deavilaubanidaniel

RVNC TRIPPLE BOTOM / RECTANGLE BREAKOUT FROM 2016/12/19 TO 2017/06/01 BREAKTOUT: 24.26 TARGET:30.04 (+24%) POSITIVE MANSFIELD

geraldelli

Long RVNC if it breaks 40.06 (the historic high). Ipo-U Turn pattern. Company is developing less invasive methods for botulinum toxin application (biggest competitor is known as Botox). Currently Trading at 997M Mkt Cap.